Significant Ownership of Zhang Xiaofan
- Large-stake filing summary
-
- Recent SEC Schedule 13D/G filings for Zhang Xiaofan focus on large-stake beneficial ownership disclosures and amendments.
- Use this view to spot new large holders, amended positions, and activist-style ownership evidence.
- Manager signature
- zhang xiaofan - Mr
- Manager location
- Shanghai
Large-stake snapshot
1 signal
Manager
Names, identifiers, and filing context for this profile.
2 identity fields
Follow Filing Activity
Follow Zhang Xiaofan with Pro and return when a new Schedule 13D/G filing changes the record on this page.
Pro alert delivery is coming soon and remains tied to source-backed filing changes rather than inferred market advice.
CIK context first
Continue from Zhang Xiaofan
Significant Ownership of Zhang Xiaofan
| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| VYNE | VYNE Therapeutics Inc. | common stock, par value $0.0001 | 14% | $2,888,491 | +$1,710,879 | 4,595,118 | +145% | Zhang Xiaofan | 13 Jul 2026 |
Schedules 13D/G Reported by Zhang Xiaofan:
| Sym | Target | Class | Ownership | Change | Current shares | Change | Value | Reporting name | Form | Report period | Filing date |
|---|
Schedule rows are parsed from SEC 13D/G filings. Open the linked filing or target page to verify the reported ownership and shares.